All of these reports prompted us to explore whether the DS variants of a known structure that had previously been shown to quickly induce necroptosis and/or significantly reduce the viability of luminal breast cancer cells could influence the activity of NFκB, cause a rapid redox imbalance as well change the actin cytoskeleton arrangement in those cells. The gene discussed is NFKB1; the disease is breast cancer.